Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Guest Column: Labeling, Packaging Front-And-Center As Unique Device Identifiers Move Forward, Survey Shows

This article was originally published in The Gray Sheet

Executive Summary

In this Gray Sheet guest column, Prism ID’s Kevin Grygiel ticks off survey responses from the device industry that shows that manufacturers are generally OK with UDI implementation, but still have trouble with some of the details. Further, the firm’s survey shows that one-third of respondents don’t believe they are ready for FDA inspections involving review of UDI activities and materials.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT034645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel